CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K Reporting owner sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −5,675 | $6.07 | $34K | 316,596 |
| 2023-12-14 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −7,000 | $5.55 | $39K | 322,271 |
| 2023-12-11 | GRAMMER ELIZABETH A | Sale 10b5-1 | −50,000 | $5.08 | $254K | 275,675 |
| 2023-12-08 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −20,000 | $5.27 | $105K | 329,271 |
| 2023-12-05 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −10,272 | $5.00 | $51K | 349,271 |
| 2023-11-30 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −3,000 | $4.50 | $14K | 359,543 |
| 2023-11-20 | Williams Laura A Chief Medical Officer | Sale | −2,581 | $4.36 | $11K | 266,191 |
| 2023-11-20 | Rosenbaum David P. Chief Development Officer | Sale | −2,835 | $4.36 | $12K | 362,543 |
| 2023-11-20 | Rosenbaum David P. Chief Development Officer | Sale | −932 | $4.36 | $4K | 113,293 |
| 2023-11-20 | Rodriguez Susan Chief Commercial Officer | Sale | −4,714 | $4.36 | $21K | 346,973 |
| 2023-11-20 | Renz Justin A Chief Financial Officer | Sale | −2,873 | $4.36 | $13K | 332,426 |
| 2023-11-20 | RAAB MICHAEL President & CEO | Sale | −11,368 | $4.36 | $50K | 867,868 |
| 2023-11-20 | GRAMMER ELIZABETH A | Sale | −2,384 | $4.36 | $10K | 325,675 |
| 2023-11-20 | Felsch Robert Ora | Sale | −1,044 | $4.36 | $5K | 117,066 |
| 2023-11-20 | Blanks Robert | Sale | −2,835 | $4.36 | $12K | 260,453 |
| 2023-11-15 | Williams Laura A Chief Medical Officer | Sale | −25,000 | $4.00 | $100K | 266,839 |
| 2023-10-10 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −1,644 | $4.00 | $7K | 365,378 |
| 2023-09-08 | Rosenbaum David P. Chief Development Officer | Sale 10b5-1 | −2,897 | $4.55 | $13K | 367,022 |
| 2023-08-21 | Rodriguez Susan Chief Commercial Officer | Sale | −4,733 | $3.55 | $17K | 348,687 |
| 2023-08-21 | Williams Laura A Chief Medical Officer | Sale | −2,591 | $3.55 | $9K | 291,839 |
Page 18 of 18 · 360 trades